Latterell Venture Partners

Latterell Venture Partners Home About LVP Goals Strategy LVP Process Team Bio's Portfolio Contact Us Welcome to Latterell Venture Partners Welcome to our website. We invite you to read our descriptive information and contact us if you have a new startup idea or wish to learn more about us. Our team has a long history of creating and building exciting new life science companies. If you have a new startup idea and the desire to build a high quality new company we look forward to hearing from you. Biotechnology and Medical Device Startups Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. We offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable us to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for our limited partners while providing major new disease treatments to help patients worldwide. LVP Resources LVP has committed capital of over $300 million to help build new biopharmaceutical, medical device, and healthcare companies. Learn More Wanted: Entrepreneurs LVP is seeking to meet healthcare entrepreneurs before their companies are seeded. Learn More LVP News Twelve LVP companies recently completed IPO's or Mergers. OncoMed, Tetralogic, and Evoke completed IPO's. Naurex Pharmaceuticals was acquired by Allergan, Meritage Pharmacaceuticals by Shire, ProteinSimple was acquired by Bio-Techne, ForteBio by Pall Corporation, Calistoga Pharmaceuticals by Gilead, Transcend Medical by Alcon/Novartis, Inova Labs by ResMed, Pathway Medical by Medrad/Bayer, and Revascular by Boston Scientific. Learn More Copyright © 2016 by Latterell Venture Partners LVP is Registered in the US Patent and Trademark Office